{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T15:30:30Z","timestamp":1792251030128,"version":"4.4.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100004721","name":"The University of Tokyo","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004721","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s00198-024-07168-4","type":"journal-article","created":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T22:01:48Z","timestamp":1719871308000},"page":"1633-1643","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Latent metabolic bone disease, skeletal dysplasia and other conditions related to low bone formation among 38 patients with subtrochanteric femoral fractures: a retrospective observational study"],"prefix":"10.1007","volume":"35","author":[{"given":"Soichiro","family":"Kimura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Sunouchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitomo","family":"Hoshino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Hidaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaomi","family":"Nangaku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Makita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kotaro","family":"Azuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taro","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehiro","family":"Matsubara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taku","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4071-5372","authenticated-orcid":false,"given":"Nobuaki","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,1]]},"reference":[{"issue":"1","key":"7168_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jbmr.1998","volume":"29","author":"E Shane","year":"2014","unstructured":"Shane E, Burr D, Abrahamsen B, Adler RA, Brown TD, Cheung AM, Cosman F, Curtis JR, Dell R, Dempster DW, Ebeling PR, Einhorn TA, Genant HK, Geusens P, Klaushofer K, Lane JM, McKiernan F, McKinney R, Ng A, Nieves J, O\u2019Keefe R, Papapoulos S, Howe TS, van der Meulen MC, Weinstein RS, Whyte MP (2014) Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res. 29(1):1\u201323","journal-title":"J Bone Miner Res."},{"key":"7168_CR2","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.bone.2016.01.002","volume":"85","author":"JC Lo","year":"2016","unstructured":"Lo JC, Hui RL, Grimsrud CD, Chandreighta M, Neugebauer RS, Gonzalez JR et al (2016) The association of race\/ethnicity and risk of atypical femur fracture among older women receiving oral bisphosphonate therapy. Bone 85:142\u2013147","journal-title":"Bone"},{"issue":"1","key":"7168_CR3","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1186\/s12891-020-03672-w","volume":"21","author":"JC Lo","year":"2020","unstructured":"Lo JC, Neugebauer RS, Ettinger B, Chandra M, Hui RL, Ott SM, Grimsrud CD, Izano MA (2020) Risk of complete atypical femur fracture with oral bisphosphonate exposure beyond three years. BMC Musculoskelet Disord. 21(1):801","journal-title":"BMC Musculoskelet Disord."},{"issue":"12","key":"7168_CR4","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1007\/s00198-019-05112-5","volume":"30","author":"JC Lo","year":"2019","unstructured":"Lo JC, Grimsrud CD, Ott SM, Chandra M, Hui RL, Ettinger B (2019) Atypical femur fracture incidence in women increases with duration of bisphosphonate exposure. Osteoporos Int. 30(12):2515\u20132520","journal-title":"Osteoporos Int."},{"issue":"1","key":"7168_CR5","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s00223-022-00952-6","volume":"111","author":"JKM Goh","year":"2022","unstructured":"Goh JKM, Koh JSB, Ng ACM, Png MA, Howe TS (2022) Bilateral atypical femur fractures after denosumab in a bisphosphonate naive patient: a case report. Calcif Tissue Int. 111(1):96\u2013101","journal-title":"Calcif Tissue Int."},{"issue":"7","key":"7168_CR6","doi-asserted-by":"publisher","first-page":"e10749","DOI":"10.1002\/jbm4.10749","volume":"7","author":"T Kaku","year":"2023","unstructured":"Kaku T, Oh Y, Sato S, Koyanagi H, Funauchi Y, Hirai T, Yuasa M, Matsukura Y, Yoshii T, Nakagawa T, Miyake S, Okawa A (2023) Prevalence of precursory signs of atypical femoral fractures in patients receiving bone-modifying agents for bone metastases: a cross-sectional study. JBMR Plus. 7(7):e10749","journal-title":"JBMR Plus."},{"key":"7168_CR7","doi-asserted-by":"publisher","first-page":"108456","DOI":"10.1016\/j.ijscr.2023.108456","volume":"108","author":"Y Omichi","year":"2023","unstructured":"Omichi Y, Toki S, Nishisho T, Harada T, Sato N, Sairyo K (2023) Atypical femoral fracture in a multiple myeloma patient undergoing treatment with denosumab: a case report and literature review. Int J Surg Case Rep. 108:108456","journal-title":"Int J Surg Case Rep."},{"issue":"1","key":"7168_CR8","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s11657-022-01166-x","volume":"17","author":"S Kumar","year":"2022","unstructured":"Kumar S, Chang R, Reyes M, Diamond T (2022) Atypical femoral fracture in a bisphosphonate-na\u00efve patient on denosumab for osteoporosis. Arch Osteoporos. 17(1):131","journal-title":"Arch Osteoporos."},{"issue":"11","key":"7168_CR9","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1007\/s00198-020-05499-6","volume":"31","author":"HI Piponov","year":"2020","unstructured":"Piponov HI, Goldstein JM, Eisenberg GM (2020) Multiple ipsilateral femoral stress fractures in a patient taking denosumab for osteoporosis-a case report. Osteoporos Int. 31(11):2263\u20132267","journal-title":"Osteoporos Int."},{"issue":"2","key":"7168_CR10","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.bone.2010.05.019","volume":"47","author":"A Giusti","year":"2010","unstructured":"Giusti A, Hamdy NA, Papapoulos SE (2010) Atypical fractures of the femur and bisphosphonate therapy: a systematic review of case\/case series studies. Bone 47(2):169\u2013180","journal-title":"Bone"},{"issue":"8","key":"7168_CR11","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1056\/NEJMoa1916525","volume":"383","author":"DM Black","year":"2020","unstructured":"Black DM, Geiger EJ, Eastell R, Vittinghoff E, Li BH, Ryan DS, Dell RM, Adams AL (2020) Atypical femur fracture risk versus fragility fracture prevention with bisphosphonates. N Engl J Med 383(8):743\u2013753","journal-title":"N Engl J Med"},{"issue":"16","key":"7168_CR12","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1056\/NEJMoa1607948","volume":"375","author":"F Cosman","year":"2016","unstructured":"Cosman F, Crittenden DB, Adachi JD, Binkley N, Czerwinski E, Ferrari S, Hofbauer LC, Lau E, Lewiecki EM, Miyauchi A, Zerbini CA, Milmont CE, Chen L, Maddox J, Meisner PD, Libanati C, Grauer A (2016) Romosozumab treatment in postmenopausal women with osteoporosis. N Engl J Med 375(16):1532\u20131543","journal-title":"N Engl J Med"},{"issue":"1","key":"7168_CR13","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1186\/s12885-019-6236-6","volume":"19","author":"M Takahashi","year":"2019","unstructured":"Takahashi M, Ozaki Y, Kizawa R, Masuda J, Sakamaki K, Kinowaki K, Umezu T, Kondoh C, Tanabe Y, Tamura N, Miura Y, Shigekawa T, Kawabata H, Baba N, Iguchi H, Takano T (2019) Atypical femoral fracture in patients with bone metastasis receiving denosumab therapy: a retrospective study and systematic review. BMC Cancer 19(1):980","journal-title":"BMC Cancer"},{"issue":"18","key":"7168_CR14","doi-asserted-by":"publisher","first-page":"100259","DOI":"10.1016\/j.jbo.2019.100259","volume":"22","author":"M Lockwood","year":"2019","unstructured":"Lockwood M, Banderudrappagari R, Suva LJ, Makhoul I (2019) Atypical femoral fractures from bisphosphonate in cancer patients - review. J Bone Oncol 22(18):100259","journal-title":"J Bone Oncol"},{"issue":"8","key":"7168_CR15","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1002\/jbmr.2818","volume":"31","author":"BJ Edwards","year":"2016","unstructured":"Edwards BJ, Sun M, West DP, Guindani M, Lin YH, Lu H, Hu M, Barcenas C, Bird J, Feng C, Saraykar S, Tripathy D, Hortobagyi GN, Gagel R, Murphy WA Jr (2016) Incidence of atypical femur fractures in cancer patients: the MD Anderson Cancer Center experience. J Bone Miner Res 31(8):1569\u20131576","journal-title":"J Bone Miner Res"},{"issue":"1","key":"7168_CR16","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.bone.2012.02.632","volume":"51","author":"JC Lo","year":"2012","unstructured":"Lo JC, Huang SY, Lee GA, Khandewal S, Provus J, Ettinger B et al (2012) Clinical correlates of atypical femoral fracture. Bone 51(1):181\u2013184","journal-title":"Bone"},{"issue":"1","key":"7168_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jbm4.10024","volume":"2","author":"HH Nguyen","year":"2018","unstructured":"Nguyen HH, van de Laarschot DM, Verkerk AJMH, Milat F, Zillikens MC, Ebeling PR (2018) Genetic risk factors for atypical femoral fractures (AFFs): a systematic review. JBMR Plus 2(1):1\u201311","journal-title":"JBMR Plus"},{"issue":"3","key":"7168_CR18","doi-asserted-by":"publisher","first-page":"17044","DOI":"10.1038\/nrdp.2017.44","volume":"13","author":"S Minisola","year":"2017","unstructured":"Minisola S, Peacock M, Fukumoto S, Cipriani C, Pepe J, Tella SH, Collins MT (2017) Tumour-induced osteomalacia. Nat Rev Dis Primers 13(3):17044","journal-title":"Nat Rev Dis Primers"},{"issue":"6","key":"7168_CR19","doi-asserted-by":"publisher","first-page":"e10506","DOI":"10.1002\/jbm4.10506","volume":"5","author":"B Hadzimuratovic","year":"2021","unstructured":"Hadzimuratovic B, Haschka J, Hartmann MA, Blouin S, Fratzl-Zelman N, Zwerina J, Kocijan R (2021) Impact of tenofovir disoproxil-induced fanconi syndrome on bone material quality: a case report. JBMR Plus 5(6):e10506","journal-title":"JBMR Plus"},{"issue":"10","key":"7168_CR20","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1007\/s00198-011-1528-y","volume":"22","author":"F Barvencik","year":"2011","unstructured":"Barvencik F, Beil FT, Gebauer M, Busse B, Koehne T, Seitz S, Zustin J, Pogoda P, Schinke T, Amling M (2011) Skeletal mineralization defects in adult hypophosphatasia\u2013a clinical and histological analysis. Osteoporos Int 22(10):2667\u20132675","journal-title":"Osteoporos Int"},{"issue":"6","key":"7168_CR21","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1007\/s00264-018-4167-5","volume":"43","author":"A Chawla","year":"2019","unstructured":"Chawla A, Kwek EBK (2019) Fractures in patients with osteopetrosis, insights from a single institution. Int Orthop 43(6):1297\u20131302","journal-title":"Int Orthop"},{"issue":"10","key":"7168_CR22","doi-asserted-by":"publisher","first-page":"e10223","DOI":"10.1002\/jbm4.10223","volume":"3","author":"K Rassie","year":"2019","unstructured":"Rassie K, Dray M, Michigami T, Cundy T (2019) Bisphosphonate use and fractures in adults with hypophosphatasia. JBMR Plus 3(10):e10223","journal-title":"JBMR Plus"},{"key":"7168_CR23","doi-asserted-by":"publisher","first-page":"347","DOI":"10.11138\/ccmbm\/2017.14.3.347","volume":"14","author":"JE Lawrence","year":"2017","unstructured":"Lawrence JE, Saeed D, Bartlett J, Carrothers AD (2017) Adult-onset hypophosphatasia diagnosed following bilateral atypical femoral fractures in a 55-year-old woman. Clin Cases Miner Bone Metab 14:347\u2013353","journal-title":"Clin Cases Miner Bone Metab"},{"issue":"6","key":"7168_CR24","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s00223-022-00949-1","volume":"110","author":"E Tsiantouli","year":"2022","unstructured":"Tsiantouli E, Biver E, Chevalley T, Petrovic R, Hannouche D, Ferrari S (2022) Prevalence of low serum alkaline phosphatase and hypophosphatasia in adult patients with atypical femur fractures. Calcif Tissue Int 110(6):703\u2013711","journal-title":"Calcif Tissue Int"},{"issue":"1","key":"7168_CR25","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/jbm4.10064","volume":"3","author":"P Peris","year":"2018","unstructured":"Peris P, Gonz\u00e1lez-Roca E, Rodr\u00edguez-Garc\u00eda SC, Del Mar L-C, Monegal A, Gua\u00f1abens N (2018) Incidence of mutations in the ALPL, GGPS1, andCYP1A1 genes in patients with atypical femoral fractures. JBMR Plus 3(1):29\u201336","journal-title":"JBMR Plus"},{"issue":"4","key":"7168_CR26","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s11914-018-0464-6","volume":"16","author":"J Starr","year":"2018","unstructured":"Starr J, Tay YKD, Shane E (2018) Current understanding of epidemiology, pathophysiology, and management of atypical femur fractures. Curr Osteoporos Rep 16(4):519\u2013529","journal-title":"Curr Osteoporos Rep"},{"issue":"9","key":"7168_CR27","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1302\/2058-5241.3.170070","volume":"3","author":"MS Larsen","year":"2018","unstructured":"Larsen MS, Schmal H (2018) The enigma of atypical femoral fractures: a summary of current knowledge. EFORT Open Rev 3(9):494\u2013500","journal-title":"EFORT Open Rev"},{"issue":"12","key":"7168_CR28","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1002\/jbmr.3629","volume":"33","author":"EL Duncan","year":"2018","unstructured":"Duncan EL (2018) Atypical femoral fracture: a fascinating story in evolution. J Bone Miner Res 33(12):2089\u20132090","journal-title":"J Bone Miner Res"},{"issue":"12","key":"7168_CR29","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1002\/jbmr.3580","volume":"33","author":"N Roca-Ayats","year":"2018","unstructured":"Roca-Ayats N, Ng PY, Garcia-Giralt N, Falc\u00f3-Mascar\u00f3 M, Cozar M, Abril JF, Quesada G\u00f3mez JM, Prieto-Alhambra D, Nogu\u00e9s X, Dunford JE, Russell RG, Baron R, Grinberg D, Balcells S, D\u00edez-P\u00e9rez A (2018) Functional characterization of a GGPPS variant identified in atypical femoral fracture patients and delineation of the role of GGPPS in bone-relevant cell types. J Bone Miner Res 33(12):2091\u20132098","journal-title":"J Bone Miner Res"},{"issue":"18","key":"7168_CR30","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1056\/NEJMc1612804","volume":"376","author":"N Roca-Ayats","year":"2017","unstructured":"Roca-Ayats N, Balcells S, Garcia-Giralt N, Falc\u00f3-Mascar\u00f3 M, Mart\u00ednez-Gil N, Abril JF, Urreizti R, Dopazo J, Quesada-G\u00f3mez JM, Nogu\u00e9s X, Mellibovsky L, Prieto-Alhambra D, Dunford JE, Javaid MK, Russell RG, Grinberg D, D\u00edez-P\u00e9rez A (2017) GGPS1 mutation and atypical femoral fractures with bisphosphonates. N Engl J Med 376(18):1794\u20131795","journal-title":"N Engl J Med"},{"issue":"14","key":"7168_CR31","doi-asserted-by":"publisher","first-page":"7395","DOI":"10.3390\/ijms22147395","volume":"22","author":"N Ugartondo","year":"2021","unstructured":"Ugartondo N, Mart\u00ednez-Gil N, Esteve M, Garcia-Giralt N, Roca-Ayats N, Ovejero D, Nogu\u00e9s X, D\u00edez-P\u00e9rez A, Rabionet R, Grinberg D, Balcells S (2021) Functional analyses of four CYP1A1 missense mutations present in patients with atypical femoral fractures. Int J Mol Sci 22(14):7395","journal-title":"Int J Mol Sci"},{"issue":"8","key":"7168_CR32","doi-asserted-by":"publisher","first-page":"e10659","DOI":"10.1002\/jbm4.10659","volume":"6","author":"W Zhou","year":"2022","unstructured":"Zhou W, Nguyen HH, van de Laarschot DM, Howe TS, Koh JSB, Milat F, van Rooij JGJ, Verlouw JAM, van der Eerden BCJ, Stevenson M, Thakker RV, Zillikens MC, Ebeling PR (2022) Whole exome sequencing in two southeast asian families with atypical femur fractures. JBMR Plus 6(8):e10659","journal-title":"JBMR Plus"},{"key":"7168_CR33","volume-title":"GeneReviews\u00ae [Internet]","author":"S LeBlanc","year":"2020","unstructured":"LeBlanc S, Savarirayan R (2020) Pycnodysostosis. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A (eds) GeneReviews\u00ae [Internet]. University of Washington, Seattle"},{"issue":"1","key":"7168_CR34","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1210\/jcem.85.1.6247","volume":"85","author":"Y Fujita","year":"2000","unstructured":"Fujita Y, Nakata K, Yasui N, Matsui Y, Kataoka E, Hiroshima K, Shiba RI, Ochi T (2000) Novel mutations of the cathepsin K gene in patients with pycnodysostosis and their characterization. J Clin Endocrinol Metab 85(1):425\u2013431","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"7168_CR35","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s12603-015-0652-3","volume":"21","author":"KS Khow","year":"2017","unstructured":"Khow KS, Shibu P, Yu SC, Chehade MJ, Visvanathan R (2017) Epidemiology and postoperative outcomes of atypical femoral fractures in older adults: a systematic review. J Nutr Health Aging 21(1):83\u201391","journal-title":"J Nutr Health Aging"},{"issue":"2","key":"7168_CR36","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s11914-021-00658-y","volume":"19","author":"W Zhou","year":"2021","unstructured":"Zhou W, van Rooij JGJ, Ebeling PR, Verkerk AJMH, Zillikens MC (2021) The genetics of atypical femur fractures-a systematic review. Curr Osteoporos Rep 19(2):123\u2013130","journal-title":"Curr Osteoporos Rep"},{"issue":"4","key":"7168_CR37","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1002\/jbmr.3928","volume":"35","author":"N Alonso","year":"2020","unstructured":"Alonso N, Larraz-Prieto B, Berg K, Lambert Z, Redmond P, Harris SE, Deary IJ, Pugh C, Prendergast J, Ralston SH (2020) Loss-of-function mutations in the ALPL gene presenting with adult onset osteoporosis and low serum concentrations of total alkaline phosphatase. J Bone Miner Res 35(4):657\u2013661","journal-title":"J Bone Miner Res"},{"issue":"2","key":"7168_CR38","doi-asserted-by":"publisher","first-page":"101851","DOI":"10.1016\/j.beem.2023.101851","volume":"38","author":"N Ito","year":"2024","unstructured":"Ito N, Hidaka N, Kato H (2024) The pathophysiology of hypophosphatemia. Best Pract Res Clin Endocrinol Metab 38(2):101851","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"7","key":"7168_CR39","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/S2213-8587(17)30138-9","volume":"5","author":"HG Bone","year":"2017","unstructured":"Bone HG, Wagman RB, Brandi ML, Brown JP, Chapurlat R, Cummings SR et al (2017) 10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension. Lancet Diabetes Endocrinol 5(7):513\u2013523","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"7168_CR40","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s11926-010-0098-x","volume":"12","author":"MI Hu","year":"2010","unstructured":"Hu MI, Lu H, Gagel RF (2010) Cancer therapies and bone health. Curr Rheumatol Rep 12(3):177\u2013185","journal-title":"Curr Rheumatol Rep"},{"key":"7168_CR41","doi-asserted-by":"publisher","first-page":"115319","DOI":"10.1016\/j.bone.2020.115319","volume":"135","author":"HH Nguyen","year":"2020","unstructured":"Nguyen HH, Lakhani A, Shore-Lorenti C, Zebaze R, Vincent AJ, Milat F, Ebeling PR (2020) Asian ethnicity is associated with atypical femur fractures in an Australian population study. Bone 135:115319","journal-title":"Bone"},{"issue":"4","key":"7168_CR42","doi-asserted-by":"publisher","first-page":"e10607","DOI":"10.1002\/jbm4.10607","volume":"6","author":"ND Dhanekula","year":"2022","unstructured":"Dhanekula ND, Crouch G, Byth K, Lau SL, Kim A, Graham E, Ellis A, Clifton-Bligh RJ, Girgis CM (2022) Asian ethnicity and femoral geometry in atypical femur fractures: independent or interdependent risk factors? JBMR Plus 6(4):e10607","journal-title":"JBMR Plus"},{"issue":"33","key":"7168_CR43","doi-asserted-by":"publisher","first-page":"8722","DOI":"10.1073\/pnas.1704460114","volume":"114","author":"AA Lloyd","year":"2017","unstructured":"Lloyd AA, Gludovatz B, Riedel C et al (2017) Atypical fracture with long-term bisphosphonate therapy is associated with altered cortical composition and reduced fracture resistance. Proc Natl Acad Sci USA 114(33):8722\u20138727","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"7168_CR44","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1002\/jbmr.2495","volume":"30","author":"T Cundy","year":"2015","unstructured":"Cundy T, Michigami T, Tachikawa K, Dray M, Collins JF, Paschalis EP, Gamsjaeger S, Roschger A, Fratzl-Zelman N, Roschger P, Klaushofer K (2015) Reversible deterioration in hypophosphatasia caused by renal failure with bisphosphonate treatment. J Bone Miner Res 30(9):1726\u20131737","journal-title":"J Bone Miner Res"},{"issue":"4","key":"7168_CR45","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1002\/jbmr.4233","volume":"36","author":"SM Jan de Beur","year":"2021","unstructured":"Jan de Beur SM, Miller PD, Weber TJ, Peacock M, Insogna K, Kumar R, Rauch F, Luca D, Cimms T, Roberts MS, San Martin J, Carpenter TO (2021) Burosumab for the treatment of tumor-induced osteomalacia. J Bone Miner Res 36(4):627\u2013635","journal-title":"J Bone Miner Res"},{"issue":"2","key":"7168_CR46","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s00198-022-06597-3","volume":"34","author":"E Ng","year":"2023","unstructured":"Ng E, Ashkar C, Seeman E, Schneider HG, Nguyen H, Ebeling PR, Sztal-Mazer S (2023) A low serum alkaline phosphatase may signal hypophosphatasia in osteoporosis clinic patients. Osteoporos Int 34(2):327\u2013337","journal-title":"Osteoporos Int"},{"issue":"12","key":"7168_CR47","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1007\/s00198-015-3272-1","volume":"26","author":"ML Bianchi","year":"2015","unstructured":"Bianchi ML (2015) Hypophosphatasia: an overview of the disease and its treatment. Osteoporos Int 26(12):2743\u20132757","journal-title":"Osteoporos Int"},{"key":"7168_CR48","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/1471-2350-10-51","volume":"10","author":"D Fauvert","year":"2009","unstructured":"Fauvert D, Brun-Heath I, Lia-Baldini AS, Bellazi L, Taillandier A, Serre JL, de Mazancourt P, Mornet E (2009) Mild forms of hypophosphatasia mostly result from dominant negative effect of severe alleles or from compound heterozygosity for severe and moderate alleles. BMC Med Genet 10:51","journal-title":"BMC Med Genet"},{"issue":"3","key":"7168_CR49","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/j.1469-1809.2011.00642.x","volume":"75","author":"E Mornet","year":"2011","unstructured":"Mornet E, Yvard A, Taillandier A, Fauvert D, Simon-Bouy B (2011) A molecular-based estimation of the prevalence of hypophosphatasia in the European population. Ann Hum Genet 75(3):439\u2013445","journal-title":"Ann Hum Genet"},{"issue":"1","key":"7168_CR50","doi-asserted-by":"publisher","first-page":"e2056","DOI":"10.1002\/mgg3.2056","volume":"11","author":"NM Beck","year":"2023","unstructured":"Beck NM, Sagaser KG, Lawson CS, Hertenstein C, Jachens A, Forster KR, Miller KA, Jelin AC, Blakemore KJ, Hoover-Fong J (2023) Not just a carrier: clinical presentation and management of patients with heterozygous disease-causing alkaline phosphatase (ALPL) variants identified through expanded carrier screening. Mol Genet Genomic Med 11(1):e2056","journal-title":"Mol Genet Genomic Med"},{"issue":"5","key":"7168_CR51","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1002\/jbmr.1565","volume":"27","author":"RA Sutton","year":"2012","unstructured":"Sutton RA, Mumm S, Coburn SP, Ericson KL, Whyte MP (2012) \u201cAtypical femoral fractures\u201d during bisphosphonate exposure in adult hypophosphatasia. J Bone Miner Res 27(5):987\u2013994","journal-title":"J Bone Miner Res"},{"issue":"2","key":"7168_CR52","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s00223-022-01048-x","volume":"112","author":"K Makris","year":"2023","unstructured":"Makris K, Mousa C, Cavalier E (2023) Alkaline phosphatases: biochemistry, functions, and measurement. Calcif Tissue Int 112(2):233\u2013242","journal-title":"Calcif Tissue Int"},{"key":"7168_CR53","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.maturitas.2015.02.009","volume":"81","author":"S Cabrerizo","year":"2015","unstructured":"Cabrerizo S, Cuadras D, Gomez-Busto F, Artaza-Artabe I, Mar\u00edn-Ciancas F, Malafarina V (2015) Serum albumin and health in older people: review and meta analysis. Maturitas 81:17\u201327","journal-title":"Maturitas"},{"issue":"19","key":"7168_CR54","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1056\/NEJMc0910389","volume":"362","author":"CM Girgis","year":"2010","unstructured":"Girgis CM, Sher D, Seibel MJ (2010) Atypical femoral fractures and bisphosphonate use. N Engl J Med 362(19):1848\u20131849","journal-title":"N Engl J Med"},{"issue":"3","key":"7168_CR55","doi-asserted-by":"publisher","first-page":"17052","DOI":"10.1038\/nrdp.2017.52","volume":"18","author":"JC Marini","year":"2017","unstructured":"Marini JC, Forlino A, B\u00e4chinger HP, Bishop NJ, Byers PH, Paepe A, Fassier F, Fratzl-Zelman N, Kozloff KM, Krakow D, Montpetit K, Semler O (2017) Osteogenesis imperfecta Nat Rev Dis Primers 18(3):17052","journal-title":"Osteogenesis imperfecta Nat Rev Dis Primers"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-024-07168-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-024-07168-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-024-07168-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T04:03:41Z","timestamp":1724990621000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-024-07168-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,1]]},"references-count":55,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["7168"],"URL":"https:\/\/doi.org\/10.1007\/s00198-024-07168-4","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,1]]},"assertion":[{"value":"30 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures were performed following the ethical standards of the Declaration of Helsinki and were approved by the institutional ethical board of the University of Tokyo Hospital [Ref. 3820].","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}